Can perimenopause cause vaginal dryness?

Yes, vaginal dryness is a direct and well-established consequence of the estrogen changes that occur during perimenopause. It is among the most common symptoms of the hormonal transition, affecting an estimated 17 to 45 percent of women during perimenopause and becoming progressively more prevalent after the final menstrual period. Unlike hot flashes and mood changes, which often improve over time as hormones settle, vaginal dryness tends to persist and frequently worsens without specific treatment.

The vaginal tissues are among the most estrogen-sensitive in the entire body. Estrogen maintains the thickness and structural integrity of vaginal walls by supporting the proliferation of epithelial cells and collagen synthesis in the underlying connective tissue. It promotes the production of glycogen by vaginal cells, which feeds lactobacillus bacteria that maintain the healthy acidic pH (below 4.5) of the vaginal environment. This acidic, lactobacillus-rich environment protects against bacterial and fungal infections and against ascending urinary tract infections. Estrogen also stimulates the cervical and vaginal glands to produce the moisture that keeps vaginal tissue lubricated. When estrogen declines and fluctuates during perimenopause, all of these functions are progressively impaired, producing what clinicians now call genitourinary syndrome of menopause (GSM).

In practice, GSM and its vaginal component produce a range of symptoms that vary in how they present. Some women experience a constant sense of dryness and tightness, a persistent feeling that the vaginal tissues are raw, irritated, or uncomfortable even at rest. Others notice symptoms primarily or exclusively during sexual activity: reduced natural lubrication, friction and discomfort during penetration, vaginal soreness or aching after sex, and in some cases light spotting from fragile tissue. The vaginal pH change associated with estrogen decline also makes women more susceptible to bacterial vaginosis and yeast infections, and many women notice they get these more frequently during perimenopause.

An important clinical point is that vaginal dryness, unlike hot flashes, does not typically improve after menopause without treatment. The estrogen-dependent mechanisms that support vaginal tissue health require ongoing estrogen input to function. As estrogen levels stabilize at the lower postmenopausal level, vaginal tissue that has not received treatment continues to thin and lose moisture over time. This is called vaginal atrophy in older terminology and is now recognized as part of the broader GSM spectrum. Treating it early, during perimenopause, before tissue changes become advanced, produces better outcomes than delaying.

Treatment options are effective and range from non-hormonal to hormonal. Over-the-counter vaginal moisturizers (not lubricants, which only temporarily reduce friction), used two to three times per week consistently, can maintain vaginal moisture over time. Personal lubricants used during sex reduce friction-related discomfort. Vaginal estrogen, available as creams, tablets, suppositories, and rings, delivers estrogen directly to vaginal tissue with minimal systemic absorption and restores tissue health at the cellular level. Local vaginal estrogen is considered safe for most women, including many who cannot or prefer not to use systemic hormone therapy, as its blood-level impact is minimal. For women who cannot use any estrogen, ospemifene (an oral SERM that acts as an estrogen agonist in vaginal tissue) is an option. Regular sexual activity, including solo stimulation, maintains blood flow and tissue health and reduces the rate of atrophy. This is not simply an anecdotal claim but is supported by evidence: studies have found that women who maintain regular sexual activity through perimenopause and into postmenopause have better-preserved vaginal tissue health compared to women who do not, independent of hormone use. The physical stimulation, increased blood flow, and mild mechanical stretching that occur during arousal and activity appear to help counteract some of the tissue thinning that estrogen decline promotes. For women without a partner, solo activity provides the same physiological benefit and is a reasonable and under-discussed aspect of vaginal health management.

Tracking your symptoms over time, using a tool like PeriPlan, can help you monitor vaginal dryness and track whether treatments are producing meaningful improvement over the months of use that are typically needed for full effect.

When to talk to your doctor: Speak directly with your provider if vaginal dryness is causing pain during sex, affecting your relationship, causing daily discomfort, or leading you to avoid activities you value. Many women do not raise this symptom because they feel embarrassed, or because they are told it is normal. It is common, but it is also highly treatable, and effective options exist. Also seek evaluation if you have postmenopausal vaginal bleeding, unusual discharge, persistent sores, or itching that does not respond to standard measures, as these require examination.

This content is for informational purposes only and does not replace medical advice. Always consult your healthcare provider about your specific situation.